AXS Investments LLC Trims Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

AXS Investments LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 72.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,845 shares of the medical equipment provider’s stock after selling 4,803 shares during the quarter. AXS Investments LLC’s holdings in Intuitive Surgical were worth $631,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. HHM Wealth Advisors LLC raised its position in Intuitive Surgical by 1,314.3% in the 1st quarter. HHM Wealth Advisors LLC now owns 99 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 92 shares during the period. Solstein Capital LLC purchased a new position in shares of Intuitive Surgical during the second quarter worth approximately $25,000. RFP Financial Group LLC increased its position in shares of Intuitive Surgical by 166.7% during the second quarter. RFP Financial Group LLC now owns 80 shares of the medical equipment provider’s stock worth $27,000 after acquiring an additional 50 shares during the period. Marquette Asset Management LLC purchased a new position in shares of Intuitive Surgical during the second quarter worth approximately $28,000. Finally, Barrett & Company Inc. purchased a new position in shares of Intuitive Surgical during the first quarter worth approximately $30,000. 82.91% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 0.4 %

NASDAQ:ISRG opened at $305.28 on Friday. Intuitive Surgical, Inc. has a 12 month low of $222.65 and a 12 month high of $358.07. The firm has a fifty day simple moving average of $284.26 and a 200-day simple moving average of $305.11. The company has a market capitalization of $107.48 billion, a P/E ratio of 71.83, a PEG ratio of 4.85 and a beta of 1.31.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $1.46 EPS for the quarter, topping the consensus estimate of $1.40 by $0.06. Intuitive Surgical had a net margin of 22.14% and a return on equity of 12.91%. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the previous year, the firm posted $0.90 earnings per share. The business’s revenue for the quarter was up 12.0% compared to the same quarter last year. Equities analysts forecast that Intuitive Surgical, Inc. will post 4.54 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 27,385 shares of Intuitive Surgical stock in a transaction on Thursday, October 26th. The shares were sold at an average price of $260.11, for a total transaction of $7,123,112.35. Following the completion of the sale, the chief executive officer now directly owns 23,551 shares in the company, valued at $6,125,850.61. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO Gary S. Guthart sold 27,385 shares of the firm’s stock in a transaction on Thursday, October 26th. The shares were sold at an average price of $260.11, for a total transaction of $7,123,112.35. Following the completion of the transaction, the chief executive officer now owns 23,551 shares of the company’s stock, valued at $6,125,850.61. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $305.68, for a total transaction of $152,840.00. Following the transaction, the director now directly owns 702 shares of the company’s stock, valued at approximately $214,587.36. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 55,208 shares of company stock worth $15,275,529. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on ISRG. Barclays raised their target price on shares of Intuitive Surgical from $314.00 to $385.00 and gave the stock an “overweight” rating in a research report on Monday, July 24th. Piper Sandler reduced their target price on shares of Intuitive Surgical from $385.00 to $325.00 and set an “overweight” rating on the stock in a research report on Friday, October 20th. TheStreet raised shares of Intuitive Surgical from a “c+” rating to a “b” rating in a research report on Monday, July 24th. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $315.00 to $350.00 and gave the stock a “buy” rating in a research report on Friday. Finally, HSBC initiated coverage on shares of Intuitive Surgical in a report on Friday. They set a “buy” rating and a $318.00 price objective on the stock. Five investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $342.71.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.